PHARMExcel to support trial delivery of world-first Covid-19 vaccine booster study.
PHARMExcel is delighted to be announced as the UK Contract Research Organisation (CRO) supporting University Hospital Southampton in the delivery of a world-first Covid-19 vaccine booster study. The Cov-Boost study, backed by £19.3 million of government funding through the Vaccines Taskforce, will be run at University Hospital Southampton, University Hospitals Dorset and the Portsmouth Research…
Sanofo-GSK vaccine showing positive Phase II data
Increasing confidence jabs work against Indian variant
US approves Pfizer COVID-19 vaccine for children aged 12 to 15
New NHS legislation provides ‘once-in-a-decade opportunity’ to centre research
PHARMExcel’s Fundraising Events 2021
The PHARMExcel team hosted their own virtual quiz night and £280.00 was raised for Macmillan Cancer Support. A great evening was had by all and Yvanne was the winner!
PHARMExcel instrumental in supporting the re-opening of Biotherapy Services DFU trial
Biotherapy Services are very pleased to announce our RAPID-1 (Diabetic Foot Ulcer) trial has enrolled and dosed its first patient following suspension of the trial due to the Covid-19 pandemic restrictions. This could only have been made possible with the collaborative approach from the PHARMExcel team, who took over the trial management in early 2020….
Reward & Recognition Award – Arturo Maldonado
Many congratulations to our Junior Clinical Trials Administrator Arturo Maldonado who has been awarded a Reward & Recognition award for his outstanding contribution to the Company. He consistently demonstrates all the Company values, is professional, polite, and always supportive of his colleagues – nothing is ever too much trouble for him. He is a true…